BioCentury
ARTICLE | Distillery Therapeutics

Increasing hepatocyte RNF13 activity for NASH

November 28, 2023 12:43 AM UTC

Increasing hepatocyte expression of the E3 ubiquitin ligase RNF13 can help treat NASH by stabilizing the E3 ligase TRIM29, which promotes proteasomal degradation of the inflammation- and lipid accumulation-promoting signaling molecule STING.

In two human liver cancer cell lines exposed to a lipid accumulation and inflammation-inducing medium, a gain-of-function screen of plasmids encoding innate immunity-regulating E3 ligases and deubiquitinating enzymes identified RNF13 overexpression as a reducer of lipid accumulation. ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article